Option Care Health, Inc. (OPCH) stock
Close on Nov 13, 2026Market cap $4.74BP/E 23.8Yield –
Earnings
Option Care Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Option Care Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026before the open | $1.49B | +4.1% | $0.38 | $0.49 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026before the open | $1.44B | +1.8% | $0.35 | $0.45 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026before the open | $1.35B | +1.3% | $0.29 | $0.40 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026before the open | $1.47B | +8.8% | $0.37 | $0.46 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025before the open | $1.44B | +12.2% | $0.32 | $0.45 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025before the open | $1.42B | +15.4% | $0.31 | $0.41 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 29, 2025before the open | $1.33B | +16.3% | $0.28 | $0.40 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | $1.35B | +19.7% | $0.35 | $0.44 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024before the open | $1.28B | +17.0% | $0.31 | $0.41 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024before the open | $1.23B | +14.8% | $0.30 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 23, 2024before the open | $1.15B | +12.8% | $0.26 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 22, 2024before the open | $1.12B | +9.5% | $0.32 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023before the open | $1.09B | +7.1% | $0.31 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023before the open | $1.07B | +9.0% | $0.63 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023after the close | $1.02B | +10.9% | $0.21 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023before the open | $1.03B | +10.8% | $0.26 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022before the open | $1.02B | +14.5% | $0.21 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022before the open | $980.80M | – | $0.19 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022before the open | $915.80M | – | $0.17 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 23, 2022before the open | $927.20M | – | $0.41 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021before the open | $891.90M | – | $0.20 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 8, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 3, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Option Care Health's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net revenue | FY2026 | $5.68B – $5.78B | $5.68B – $5.78B | Reaffirmed | Jul 29, 2026 |
| Net revenueGAAP | FY2026 | $5.80B – $6.00B | – | New | Feb 24, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $480.00M – $495.00M | $480.00M – $505.00M | Lowered | Jul 29, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $480.00M – $505.00M | – | New | Feb 24, 2026 |
| Adjusted diluted earnings per sharenon-GAAP | FY2026 | $1.85 – $1.92 | $1.82 – $1.92 | Raised | Jul 29, 2026 |
| Adjusted diluted earnings per sharenon-GAAP | FY2026 | $1.82 – $1.92 | – | New | Feb 24, 2026 |
| Cash provided by operating activities | FY2026 | $320.00M | $320.00M | Reaffirmed | Jul 29, 2026 |
| Cash provided by operating activitiesGAAP | FY2026 | $340.00M | – | New | Feb 24, 2026 |
Guidance vs results
The last range Option Care Health gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted diluted earnings per share | $1.68 – $1.72 | $1.72Σ4Q | Within range |
| FY2025 | Revenue | $5.60B – $5.65B | $5.65BΣ4Q | Within range |
Guidance history
Every forecast Option Care Health put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Jul 29, 2026 | Adjusted EBITDA | FY2026 | $480.00M – $495.00M | Lowered |
| Jul 29, 2026 | Adjusted diluted earnings per share | FY2026 | $1.85 – $1.92 | Raised |
| Jul 29, 2026 | Cash provided by operating activities | FY2026 | $320.00M | Reaffirmed |
| Jul 29, 2026 | Net revenue | FY2026 | $5.68B – $5.78B | Reaffirmed |
| Apr 30, 2026 | Adjusted EBITDA | FY2026 | $480.00M – $505.00M | Reaffirmed |
| Apr 30, 2026 | Adjusted diluted earnings per share | FY2026 | $1.82 – $1.92 | Reaffirmed |
| Apr 30, 2026 | Cash provided by operating activities | FY2026 | $320.00M | New |
| Apr 30, 2026 | Net revenue | FY2026 | $5.68B – $5.78B | Lowered |
| Feb 24, 2026 | Adjusted EBITDA | FY2026 | $480.00M – $505.00M | New |
| Feb 24, 2026 | Adjusted diluted earnings per share | FY2026 | $1.82 – $1.92 | New |
| Feb 24, 2026 | Cash provided by operating activities | FY2026 | $340.00M | New |
| Feb 24, 2026 | Net revenue | FY2026 | $5.80B – $6.00B | New |
| Jan 12, 2026 | Adjusted EBITDA | FY2026 | $480.00M – $505.00M | New |
| Jan 12, 2026 | Adjusted diluted EPS | FY2026 | $1.82 – $1.92 | New |
| Jan 12, 2026 | Net revenue | FY2026 | $5.80B – $6.00B | New |
| Oct 30, 2025 | Adjusted EBITDA | FY2025 | $468.00M – $473.00M | New |
| Oct 30, 2025 | Adjusted diluted earnings per share | FY2025 | $1.68 – $1.72 | New |
| Oct 30, 2025 | Effective tax rate | FY2025 | 25% – 27% | New |
| Oct 30, 2025 | Cash flow from operations | FY2025 | $320.00M | New |
| Oct 30, 2025 | Net interest expense | FY2025 | $55.00M – $57.00M | Lowered |
| Oct 30, 2025 | Net revenue | FY2025 | $5.60B – $5.65B | New |
| Jul 30, 2025 | Adjusted EBITDA | FY2025 | $465.00M – $475.00M | Raised |
| Jul 30, 2025 | Adjusted diluted earnings per share | FY2025 | $1.65 – $1.72 | Raised |
| Jul 30, 2025 | Effective tax rate | FY2025 | 25% – 27% | Reaffirmed |
| Jul 30, 2025 | Cash flow from operations | FY2025 | $320.00M | Raised |
| Jul 30, 2025 | Net interest expense | FY2025 | $55.00M – $60.00M | Lowered |
| Jul 30, 2025 | Net revenue | FY2025 | $5.50B – $5.65B | Raised |
| Apr 29, 2025 | Adjusted EBITDA | FY2025 | $455.00M – $470.00M | Raised |
| Apr 29, 2025 | Adjusted diluted earnings per share | FY2025 | $1.61 – $1.70 | Raised |
| Apr 29, 2025 | Effective tax rate | FY2025 | 25% – 27% | New |
| Apr 29, 2025 | Cash flow from operations | FY2025 | $320.00M | New |
| Apr 29, 2025 | Net interest expense | FY2025 | $55.00M – $60.00M | Lowered |
| Apr 29, 2025 | Net revenue | FY2025 | $5.40B – $5.60B | Raised |
| Feb 26, 2025 | Adjusted EBITDA | FY2025 | $450.00M – $470.00M | Raised |
| Feb 26, 2025 | Adjusted diluted earnings per share | FY2025 | $1.59 – $1.69 | Reaffirmed |
| Feb 26, 2025 | Effective tax rate | FY2025 | 25% – 27% | New |
| Feb 26, 2025 | Cash flow from operations | FY2025 | $320.00M | New |
| Feb 26, 2025 | Net interest expense | FY2025 | $55.00M – $60.00M | Lowered |
| Feb 26, 2025 | Net revenue | FY2025 | $5.30B – $5.50B | New |
| Jan 13, 2025 | Adjusted EBITDA | FY2025 | $445.00M – $465.00M | New |
| Jan 13, 2025 | Adjusted EPS | FY2025 | $1.59 – $1.69 | New |
| Jan 13, 2025 | Net revenue | FY2025 | $5.20B – $5.40B | New |
| Oct 30, 2024 | Adjusted EBITDA | FY2024 | $438.00M – $443.00M | Narrowed |
| Oct 30, 2024 | Effective tax rate | FY2024 | 26% – 28% | Reaffirmed |
| Oct 30, 2024 | Cash flow from operations | FY2024 | $300.00M | Raised |
| Oct 30, 2024 | Net interest expense | FY2024 | $55.00M – $60.00M | Lowered |
| Oct 30, 2024 | Net revenue | FY2024 | $4.90B – $4.95B | Raised |
| Jul 31, 2024 | Adjusted EBITDA | FY2024 | $435.00M – $450.00M | Raised |
| Jul 31, 2024 | Effective tax rate | FY2024 | 26% – 28% | New |
| Jul 31, 2024 | Cash flow from operations | FY2024 | $300.00M | Reaffirmed |
| Jul 31, 2024 | Net interest expense | FY2024 | $55.00M – $60.00M | Lowered |
| Jul 31, 2024 | Net revenue | FY2024 | $4.75B – $4.85B | Raised |
| Apr 23, 2024 | Adjusted EBITDA | FY2024 | $430.00M – $450.00M | Raised |
| Apr 23, 2024 | Effective tax rate | FY2024 | 26% – 28% | Reaffirmed |
| Apr 23, 2024 | Cash flow from operations | FY2024 | $300.00M | Raised |
| Apr 23, 2024 | Net interest expense | FY2024 | $55.00M – $60.00M | Lowered |
| Apr 23, 2024 | Net revenue | FY2024 | $4.65B – $4.80B | New |
| Feb 22, 2024 | Adjusted EBITDA | FY2024 | $425.00M – $450.00M | New |
| Feb 22, 2024 | effective tax rate | FY2024 | 26% – 28% | New |
| Feb 22, 2024 | net interest expense | FY2024 | $55.00M – $60.00M | New |
| Feb 22, 2024 | Cash flow from operations | FY2024 | $300.00M | New |
| Feb 22, 2024 | Net revenue | FY2024 | $4.60B – $4.80B | New |
| Oct 25, 2023 | Adjusted EBITDA | FY2023 | $420.00M – $425.00M | Raised |
| Oct 25, 2023 | effective tax rate | FY2023 | 27% | Lowered |
| Oct 25, 2023 | Cash flow from operations | FY2023 | $350.00M | Raised |
| Oct 25, 2023 | net interest expense | FY2023 | $52.00M – $54.00M | Lowered |
| Oct 25, 2023 | Net revenue | FY2023 | $4.23B – $4.28B | Narrowed |
| Jul 27, 2023 | Adjusted EBITDA | FY2023 | $415.00M – $425.00M | Raised |
| Jul 27, 2023 | effective tax rate | FY2023 | 27% – 29% | Reaffirmed |
| Jul 27, 2023 | Cash Flow from Operations | FY2023 | $350.00M | Raised |
| Jul 27, 2023 | net interest expense | FY2023 | $55.00M – $59.00M | Lowered |
| Jul 27, 2023 | Net Revenue | FY2023 | $4.20B – $4.30B | Narrowed |
| May 3, 2023 | Adjusted EBITDA | FY2023 | $380.00M – $395.00M | Raised |
| May 3, 2023 | effective tax rate | FY2023 | 27% – 29% | Reaffirmed |
| May 3, 2023 | Cash Flow from Operations | FY2023 | $240.00M | Raised |
| May 3, 2023 | net interest expense | FY2023 | $61.00M – $65.00M | Lowered |
| May 3, 2023 | Net Revenue | FY2023 | $4.15B – $4.38B | Reaffirmed |
| Feb 23, 2023 | Adjusted EBITDA | FY2023 | $370.00M – $390.00M | New |
| Feb 23, 2023 | effective tax rate | FY2023 | 27% – 29% | New |
| Feb 23, 2023 | Cash flow from operations | FY2023 | $240.00M | New |
| Feb 23, 2023 | net interest expense | FY2023 | $61.00M – $65.00M | Lowered |
| Feb 23, 2023 | Net revenue | FY2023 | $4.15B – $4.38B | New |
| Oct 27, 2022 | Adjusted EBITDA | FY2022 | $336.00M – $341.00M | Narrowed |
| Oct 27, 2022 | Cash Flow from Operations | FY2022 | $250.00M | Reaffirmed |
| Oct 27, 2022 | Net Revenue | FY2022 | $3.90B – $3.95B | Raised |
| Jul 27, 2022 | Adjusted EBITDA | FY2022 | $330.00M – $342.00M | Raised |
| Jul 27, 2022 | Cash Flow from Operations | FY2022 | $250.00M | Raised |
| Jul 27, 2022 | Net Revenue | FY2022 | $3.85B – $3.95B | Raised |
| Apr 28, 2022 | Adjusted EBITDA | FY2022 | $320.00M – $335.00M | Raised |
| Apr 28, 2022 | Cash Flow from Operations | FY2022 | $230.00M | Reaffirmed |
| Apr 28, 2022 | Net Revenue | FY2022 | $3.75B – $3.90B | Raised |
| Feb 23, 2022 | Adjusted EBITDA | FY2022 | $310.00M – $330.00M | New |
| Feb 23, 2022 | Cash flow from operations | FY2022 | $230.00M | New |
| Feb 23, 2022 | Net revenue | FY2022 | $3.65B – $3.85B | New |
| Nov 4, 2021 | Adjusted EBITDA | FY2021 | $283.00M – $288.00M | New |
| Nov 4, 2021 | Cash Flow from Operations | FY2021 | $180.00M | New |
| Nov 4, 2021 | Net Revenue | FY2021 | $3.35B – $3.50B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Option Care Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
See a number that looks wrong?